Immunotherapy

The key difference is in the approach. Chemotherapy and radiation directly target and kill cancer cells, often causing collateral damage to healthy cells.

Immunotherapy, on the other hand, works by enhancing the body’s immune response, allowing it to recognize and eliminate cancer cells more effectively. This targeted approach can lead to fewer side effects and long-term benefits.

Immunotherapy has shown promise in treating a wide range of cancers. It has been particularly successful in advanced melanoma, lung cancer, bladder cancer, kidney cancer, and certain types of lymphoma. Research continues to expand the list of cancers that can benefit from immunotherapy.

Immunotherapy encompasses various techniques, including:

• Checkpoint inhibitors, which block proteins that prevent immune cells from attacking cancer.
• CAR-T cell therapy, where immune cells are genetically modified to target specific cancer antigens.
• Cancer vaccines, which stimulate the immune system to recognize and attack cancer cells.
• Monoclonal antibodies, designed to target specific molecules on cancer cells.

Yes, immunotherapy can have side effects, but they tend to differ from those of traditional treatments. Common side effects may include fatigue, skin reactions, diarrhea, or immune-related adverse events like inflammation in various organs. These side effects of immunotherapy  are usually manageable and are closely monitored by healthcare providers.

Immunotherapy’s effectiveness varies from patient to patient and depends on several factors, including the type and stage of cancer, the patient’s overall health, and the specific immunotherapy used.

Some patients experience remarkable responses, while others may not benefit as significantly. It is important for healthcare professionals to assess individual cases and tailor treatment plans accordingly.